Linked Data API

Show Search Form

Search Results

1138233
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Armed Forces more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps the Government taking to expedite the availability of medicinal cannabis for soldiers suffering from PTSD. more like this
star this property tabling member constituency Birkenhead more like this
star this property tabling member printed
Frank Field more like this
star this property uin 275687 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s Specialist Register to prescribe cannabis-based products for medicinal use (CBPM), where it is clinically appropriate and in the best interest of patients. Whilst the law does not restrict the conditions for which these products may be prescribed, interim guidance has been issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists. The use of medicinal cannabis to treat post-traumatic stress disorder (PTSD) is not considered, as the interim guidance focuses only on areas where the evidence base is most developed.</p><p>The National Institute for Health and Care Excellence (NICE) has been commissioned to develop updated clinical guidelines on the prescribing of CBPM, the scope of which is limited to the management of chronic pain, intractable nausea and vomiting, spasticity and severe treatment-resistant epilepsy, areas where the evidence base is most developed. The guidelines will be published by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for identifying and assessing relevant studies and delivering such guidance. NICE is expected to consult on the draft guidance between 23 July – 20 August 2019. This guidance will be routinely updated to take account of emerging evidence.</p><p>An initial impact assessment ‘Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001’ was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication and disorders unresponsive to existing treatments.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:42:32.147Zmore like thismore than 2019-07-18T09:42:32.147Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
478
unstar this property label Biography information for Frank Field more like this
1138176
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions he is having with local authorities in London on increasing access to the PrEP Impact trial. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275775 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. All information regarding the Trial, including the research clinics which are open to recruitment is available at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/" target="_blank">https://www.prepimpacttrial.org.uk/</a></p><p>Following funding from NHS England to pay for extra PrEP drug and research costs and the Secretary of State’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country.</p><p>In London, boroughs have so far agreed to accept 60% of the total number of additional places available to them, which equates to over 4,000 extra places on the Trial. London local authority commissioners have been asked to confirm that they will accept the remaining 40% of additional places available to them by the end of August at the latest. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:39:40.61Zmore like thismore than 2019-07-18T09:39:40.61Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138175
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to advertise extra places on the PrEP Impact trial to people who are at risk of HIV. more like this
star this property tabling member constituency Bermondsey and Old Southwark more like this
star this property tabling member printed
Neil Coyle more like this
star this property uin 275774 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>The pre-exposure prophylaxis (PrEP) Impact Trial is managed by the Trial Sponsor. Recruitment to places in the Trial is managed locally by participating clinics. All information regarding the Trial, including the research clinics which are open to recruitment is available at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/" target="_blank">https://www.prepimpacttrial.org.uk/</a></p><p>Following funding from NHS England to pay for extra PrEP drug and research costs and the Secretary of State’s announcement on 30 January that the number of places on the PrEP Impact Trial would be doubled to 26,000, expansion of the Trial is now underway across the country.</p><p>In London, boroughs have so far agreed to accept 60% of the total number of additional places available to them, which equates to over 4,000 extra places on the Trial. London local authority commissioners have been asked to confirm that they will accept the remaining 40% of additional places available to them by the end of August at the latest. Participation in the Trial is on a voluntary basis and it is for research clinics and local authorities to decide whether they wish to take part.</p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:35:43.907Zmore like thismore than 2019-07-18T09:35:43.907Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4368
unstar this property label Biography information for Neil Coyle more like this
1138094
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Irritable Bowel Syndrome: Cannabis more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using medicinal cannabis to treat Irritable Bowel Syndrome. more like this
star this property tabling member constituency Brigg and Goole more like this
star this property tabling member printed
Andrew Percy more like this
star this property uin 275738 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>An initial impact assessment Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001 was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p> </p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication, including pain and other disorders unresponsive to existing treatments.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275737 more like this
star this property question first answered
less than 2019-07-18T09:33:54.507Zmore like thismore than 2019-07-18T09:33:54.507Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3939
unstar this property label Biography information for Andrew Percy more like this
1138091
star this property registered interest false more like this
star this property date less than 2019-07-10more like thismore than 2019-07-10
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Analgesics more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential merits of using medicinal cannabis for pain relief. more like this
star this property tabling member constituency Brigg and Goole more like this
star this property tabling member printed
Andrew Percy more like this
star this property uin 275737 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>An initial impact assessment Rescheduling of cannabis-based products for medicinal use under the Misuse of Drugs Regulations 2001 was published alongside The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018. A copy of this impact assessment is available at the following link:</p><p> </p><p><a href="http://www.legislation.gov.uk/uksi/2018/1055/impacts" target="_blank">http://www.legislation.gov.uk/uksi/2018/1055/impacts</a></p><p> </p><p>This set out the approach that the Government proposed to take in assessing the costs and benefits of the change in the law at a population level, with regard to the rescheduling of CBPM. The analysis is limited to the five medical conditions where there is most evidence. These five conditions are multiple sclerosis – pain or muscle spasticity; chemotherapy-induced nausea and vomiting; severe treatment-resistant epilepsy in children - specifically Dravet Syndrome and Lennox-Gastaut Syndrome only; chronic pain in adults and appetite and weight loss associated with HIV/AIDS.</p><p>To further the evidence-base, the National Institute for Health Research has issued two calls for research in this area and is working with the industry and researchers to ensure that the evidence is developed in a way that will inform decisions on public funding. This research will be open to all good quality proposals covering any indication, including pain and other disorders unresponsive to existing treatments.</p><p> </p>
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property grouped question UIN 275738 more like this
star this property question first answered
less than 2019-07-18T09:33:54.46Zmore like thismore than 2019-07-18T09:33:54.46Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
3939
unstar this property label Biography information for Andrew Percy more like this
1138449
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Sexually Transmitted Infections more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if he will increase funding for sexual health services to tackle the increases in cases of syphilis and gonorrhoea in England. more like this
star this property tabling member constituency Brighton, Kemptown more like this
star this property tabling member printed
Lloyd Russell-Moyle more like this
star this property uin 276266 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Exeter (Rt. Hon Ben Bradshaw MP) on 8 May 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-06-07/261463/" target="_blank">261463</a>.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:31:11.413Zmore like thismore than 2019-07-18T09:31:11.413Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4615
unstar this property label Biography information for Lloyd Russell-Moyle more like this
1138870
star this property registered interest false more like this
star this property date less than 2019-07-15more like thismore than 2019-07-15
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Public Health: Finance more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the amount of funding which will be allocated to local authorities for public health in 2020-21 in the event that the spending review is postponed. more like this
star this property tabling member constituency Dulwich and West Norwood more like this
star this property tabling member printed
Helen Hayes more like this
star this property uin 277233 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>2020/21 allocations to local authorities for public health functions will be confirmed in due course.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:26:21.767Zmore like thismore than 2019-07-18T09:26:21.767Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4510
unstar this property label Biography information for Helen Hayes more like this
1138460
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Smoking more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many and what proportion of Clinical Commissioning Groups do not allow varenicline and other stop smoking treatments to be prescribed to patients in primary care; and if he will make a statement. more like this
star this property tabling member constituency Corby more like this
star this property tabling member printed
Tom Pursglove more like this
star this property uin 276206 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>NHS England has advised that, because this is a locally commissioned service, they do not hold this information centrally.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:24:56.93Zmore like thismore than 2019-07-18T09:24:56.93Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4369
unstar this property label Biography information for Tom Pursglove more like this
1138448
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Public Health: Finance more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how much funding will be provided to local authorities for public health in 2020-2021 if the Government’s spending review is postponed. more like this
star this property tabling member constituency Brighton, Kemptown more like this
star this property tabling member printed
Lloyd Russell-Moyle more like this
star this property uin 276265 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>2020/21 allocations to local authorities will be confirmed in due course.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:23:22.713Zmore like thismore than 2019-07-18T09:23:22.713Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4615
unstar this property label Biography information for Lloyd Russell-Moyle more like this
1138450
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading HIV Infection: Drugs more like this
unstar this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps he is taking to find a long-term and sustainable funding package to ensure PrEP is available to all who require it. more like this
star this property tabling member constituency Brighton, Kemptown more like this
star this property tabling member printed
Lloyd Russell-Moyle more like this
star this property uin 276267 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>The 36 month pre-exposure prophylaxis (PrEP) Impact Trial is scheduled to continue until autumn 2020. Work is now starting to consider future commissioning for PrEP after the trial has ended, which includes consideration of funding options.</p> more like this
star this property answering member constituency South Ribble more like this
star this property answering member printed Seema Kennedy remove filter
star this property question first answered
less than 2019-07-18T09:20:23.147Zmore like thismore than 2019-07-18T09:20:23.147Z
star this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4615
unstar this property label Biography information for Lloyd Russell-Moyle more like this